+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

From
Global Influenza Vaccines Market 2021 - 2027 - Product Thumbnail Image

Global Influenza Vaccines Market 2021 - 2027

  • Report
  • April 2021
  • 275 Pages
From
Global Preventive Vaccines Market, 2020-2030 - Product Thumbnail Image

Global Preventive Vaccines Market, 2020-2030

  • Report
  • April 2020
  • 248 Pages
From
From
From
From
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
From
From
Global Vaccine Adjuvants Market - Product Thumbnail Image

Global Vaccine Adjuvants Market

  • Report
  • June 2021
  • 243 Pages
From
From
Loading Indicator